PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-No auction for Vectura as Carlyle declares $1.3 bln takeover bid final

Tue, 10th Aug 2021 17:02

(Recasts, adds detail, background)

By Yadarisa Shabong

Aug 10 (Reuters) - The takeover battle between tobacco giant
Philip Morris and private equity firm Carlyle for
inhaled treatments maker Vectura will not be heading to
the auction ring on Wednesday after Carlyle said it will not
raise its bid.

U.S.-based Carlyle on Tuesday declared final its 155 pence
per Vectura share offer, which it sweetened last week to value
the British company at about 958 million pounds ($1.33 billion).
The proposal is below an increased 165 pence bid from Philip
Morris on Sunday.

Britain's takeover regulator on Monday had intervened in the
battle, saying that it would enter a rare head-to-head auction https://www.reuters.com/world/uk/britains-takeover-regulator-intervenes-battle-drugmaker-vectura-2021-08-09
if the bidders do not make final bids by Tuesday 1600 GMT (1700
BST).

Only a handful of British takeover fights have gone to
auction, with the highest profile in recent years being the
battle in 2018 for pay-television group Sky when Comcast
emerged as the winner of a single-day three round
blind auction.

London-listed shares of Vectura closed at 163.4 pence on
Tuesday after hitting a more than five-year high of 176 pence
earlier in the session. They have gained 33% in value since
Carlyle's first offer in May.

Vectura has been the target of several approaches since May
from the U.S.-based groups, which are eyeing the drugmaker's
expertise with inhalable formulations and device designs for
respiratory therapies for illnesses such as asthma.

The London-listed company had voiced its support for the
Carlyle offer last week, saying that it may be better positioned
under the ownership of the private equity firm, while noting the
uncertainties that could arise for its stakeholders as a result
of being owned by the Marlboro cigarette-maker.

However, Vectura withdrew its backing and also withheld
support for the higher offer from Philip Morris following the
intervention from the Takeover Panel.

Vectura did not immediately respond to a request for
comment.

A deal with either one of the U.S. companies would require
shareholder approval.
($1 = 0.7229 pounds)

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shounak
Dasgupta and Lisa Shumaker)

More News
18 Aug 2021 09:51

Philip Morris buys 22.6% stake in Vectura as experts warn against deal

(Sharecast News) - US tobacco giant Philip Morris International bought a 22.6% stake in London-listed inhaler-maker Vectura, as health experts warned investors not to approve a takeover.

Read more
17 Aug 2021 16:06

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
12 Aug 2021 17:53

TOP NEWS: Philip Morris GBP1 billion bid wins Vectura backing

TOP NEWS: Philip Morris GBP1 billion bid wins Vectura backing

Read more
12 Aug 2021 17:28

UPDATE 2-UK's Vectura bows to sweetened 1.1 bln stg Philip Morris offer

(Recasts, adds background, shares)By Yadarisa ShabongAug 12 (Reuters) - Cigarette maker Philip Morris won the support of Vectura for its 1.1 billion pound ($1.5 billion) takeover offer for the inhaled treatments maker after outbidding private equi...

Read more
12 Aug 2021 17:13

Philip Morris wins takeover battle for inhaler maker Vectura

(Sharecast News) - US tobacco giant Philip Morris has won the battle for London-listed inhaler maker Vectura.

Read more
11 Aug 2021 15:55

UPDATE 3-Americans vie for UK's Meggitt as TransDigm makes $9.7 bln overture

* Meggitt gets possible 900p/share offer from TransDigm* Shares hit fresh record high of 846p* Company continues to back Parker-Hannifin offer (Adds background, share moves of TransDigm and Parker)By Yadarisa Shabong and Pushkala AripakaAug 11 (Reut...

Read more
11 Aug 2021 15:55

UPDATE 2-Americans vie for UK engineer Meggitt as TransDigm makes $9.7 billion overture

* Meggitt gets possible 900p/share offer from TransDigm* Shares hit fresh record high of 846p* Company continues to back Parker-Hannifin offer (Adds shares, detail, background)Aug 11 (Reuters) - A U.S. bidding battle could be brewing for UK aerospa...

Read more
11 Aug 2021 15:55

UPDATE 2-Americans vie for UK engineer Meggitt as TransDigm makes $9.7 billion overture

* Meggitt gets possible 900p/share offer from TransDigm* Shares hit fresh record high of 846p* Company continues to back Parker-Hannifin offer (Adds shares, detail, background)Aug 11 (Reuters) - A U.S. bidding battle could be brewing for UK aerospa...

Read more
11 Aug 2021 09:33

TOP NEWS: Vectura to decide own fate after Carlyle swerves auction

TOP NEWS: Vectura to decide own fate after Carlyle swerves auction

Read more
11 Aug 2021 08:17

LONDON BRIEFING: Avast results strong ahead of NortonLifeLock merger

LONDON BRIEFING: Avast results strong ahead of NortonLifeLock merger

Read more
11 Aug 2021 07:59

Carlyle says Vectura offer is final, paves way for PMI

(Sharecast News) - US tobacco giant Philip Morris looks set to potentially clinch the deal for Vectura after rival suitor Carlyle said it would not be upping its offer for the London-listed inhaler maker.

Read more
10 Aug 2021 17:16

UPDATE: No auction for Vectura as Carlyle opts not to raise bid

UPDATE: No auction for Vectura as Carlyle opts not to raise bid

Read more
10 Aug 2021 12:19

LONDON MARKET MIDDAY: Stocks mixed as investors eye US inflation

LONDON MARKET MIDDAY: Stocks mixed as investors eye US inflation

Read more
10 Aug 2021 10:38

Philip Morris changes Vectura bid to takeover offer ahead of auction

Philip Morris changes Vectura bid to takeover offer ahead of auction

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.